510(k) Report

510(k) · Cleared

Cleared

TumorSight Viz

K231130510(k) TraditionalCleared Dec 26, 2023250-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

SimBioSys, Inc. · QIH Automated Radiological Image Processing Software

Cleared on Dec 26, 2023 as substantially equivalent to K092954 (Confirma, Inc., 2009) after a 250-day review. Its family tree reaches back 11 generations to 1991. 2 later devices descend from it.

Decided
Dec 26, 2023
Review
250 days
Class
Class II
Product code
QIH
Recalls
None
Predicates
1

Its longest line of descent runs back 11 generations to K913770 (1991). 75 ancestors in all, the oldest K896095 (1990). 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2008: 1 other ancestor2006: 1 other ancestor2005: 2 other ancestors2004: 5 other ancestors2003: 7 other ancestors1996: 5 other ancestors2002: 6 other ancestors2001: 11 other ancestors2000: 4 other ancestors1999: 2 other ancestors1998: 5 other ancestors1991: 3 other ancestors1997: 2 other ancestors1995: 3 other ancestors1994: 5 other ancestors1992: 1 other ancestor1990: 1 other ancestor2024: 1 descendant cleared2025: 1 descendant clearedK913770 · Advantage V.S. CT/MR Rad Diagnostic Workstation · General Electric Co. · 1991K960613 · GE Advantage Windows Review Workstation · GE Medical Systems · 1996K020483 · Advantage Workstation 4.1 · GE Medical Systems · 2002 · recalledK023003 · Imagechecker-CT Workstation · R2 Technology, Inc. · 2002×2: 2 generations cleared close together, K032748 (2003), K040305 (2004) K043333 · VITREA2, Version 3.7 Medical Image Processing System · Vital Images, Inc. · 2004 · recalledK052963 · Mediq Version 1.0 · Clario Medical Imaging, Inc. · 2005K080196 · Z3D Contrast Acuity · Clario Medical Imaging, Inc. · 2008K081556 · Cadstream, Version 5.0 · Confirma, Inc. · 2009K092954 · Cadstream Version 5 · Confirma, Inc. · 2009 · recalled1990200020102020
  1. Root · 11 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 7 generations between
  3. 3 generations backK080196 Z3D Contrast AcuityClario Medical Imaging, Inc. · 2008
  4. 2 generations backK081556 Cadstream, Version 5.0Confirma, Inc. · 2009
  5. 1 generation backK092954 Cadstream Version 5Confirma, Inc. · 2009 · Recalled
  6. This deviceK231130 TumorSight VizSimBioSys, Inc. · 2023
  7. Descendant · cites it directly · 1 of its ownK243189 TumorSight VizSimBioSys, Inc. · 2024
  8. Descendant · 2 generations on · 0 of its ownK251766 TumorSight VizSimBioSys, Inc. · 2025
Show all 11 generations
  1. Root · 11 generations backK913770 Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co. · 1991
  2. 10 generations backK960613 GE Advantage Windows Review WorkstationGE Medical Systems · 1996
  3. 9 generations backK020483 Advantage Workstation 4.1GE Medical Systems · 2002 · Recalled
  4. 8 generations backK023003 Imagechecker-CT WorkstationR2 Technology, Inc. · 2002
  5. 7 generations backK032748 VITREA2, Version 3.4 Medical Image Processing SoftwareVital Images, Inc. · 2003 · Recalled
  6. 6 generations backK040305 VITREA2 Version 3.5Vital Images, Inc. · 2004
  7. 5 generations backK043333 VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc. · 2004 · Recalled
  8. 4 generations backK052963 Mediq Version 1.0Clario Medical Imaging, Inc. · 2005
  9. 3 generations backK080196 Z3D Contrast AcuityClario Medical Imaging, Inc. · 2008
  10. 2 generations backK081556 Cadstream, Version 5.0Confirma, Inc. · 2009
  11. 1 generation backK092954 Cadstream Version 5Confirma, Inc. · 2009 · Recalled
  12. This deviceK231130 TumorSight VizSimBioSys, Inc. · 2023

Most influential descendants

Showing 2 of 2 · See all
  • K243189TumorSight VizSimBioSys, Inc. · 2024 · cites it directly1descendant
  • K251766TumorSight VizSimBioSys, Inc. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−11K913770Advantage V.S. CT/MR Rad Diagnostic WorkstationGeneral Electric Co.1991—
−10K960613GE Advantage Windows Review WorkstationGE Medical Systems1996—
−9K020483Advantage Workstation 4.1GE Medical Systems20022
−8K023003Imagechecker-CT WorkstationR2 Technology, Inc.2002—
−7K032748VITREA2, Version 3.4 Medical Image Processing SoftwareVital Images, Inc.20032
−6K040305VITREA2 Version 3.5Vital Images, Inc.2004—
−5K043333VITREA2, Version 3.7 Medical Image Processing SystemVital Images, Inc.20041
−4K052963Mediq Version 1.0Clario Medical Imaging, Inc.2005—
−3K080196Z3D Contrast AcuityClario Medical Imaging, Inc.2008—
−2K081556Cadstream, Version 5.0Confirma, Inc.2009—
−1K092954Cadstream Version 5Confirma, Inc.20093
0 (this device)K231130TumorSight VizSimBioSys, Inc.2023—
+1K243189TumorSight VizSimBioSys, Inc.2024—
+2K251766TumorSight VizSimBioSys, Inc.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199010
199130
199210
199450
199530
199650
199720
199850
199920
200040
2001110
200260
200370
200450
200520
200610
200810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202410
202510
FIG. 1 — Lineage of K231130, 1991–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QIH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QIH device

  1. #1 K213998 cvi42 Auto Imaging Software Applicationscore 23.5 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K092954Cadstream Version 5
Summary page 4
…uct Code: QIH Committee/Panel: Radiology Device Class: II Type of 510(k) Submission: Traditional Identification of the Legally Marketed Predicate Device Predicate #: K092954 Predicate Trade Name: CADstream Version 5 Product Code: LLZ Device Description TumorSight Viz is an image processing system desig…
Confirma, Inc.20093

Also cleared against K092954: 1 other device →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K243189TumorSight VizSimBioSys, Inc.20241

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 32 years and passes through 7 companies; a new generation was cleared every 11 months on median.
  • 18 of the 75 ancestors have a recall of any class.
  • Of its descendants, K243189 (SimBioSys, Inc., 2024) has gone furthest, with 1 descendant of its own.
  • 1 other device also cites its predicate K092954.

How does its category compare?

All QIH devices

QIH Automated Radiological Image Processing Software: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · QIH

94in 2025

2019: 22020: 112021: 192022: 252023: 452024: 642025: 942026 (partial year): 78
2007high 94 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QIH

150in 2025

2020: 145 days median2021: 125 days median2022: 134 days median2023: 151 days median2024: 141 days median2025: 150 days median2026 (partial year): 130 days median
2007high 151 (2023) · low 125 (2021)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · QIH

1so far in 2026, the most since 2007

2026 (partial year): 1
2007high 1 (2026) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · QIH

4in 2025

2024: 22025: 4
2007high 4 (2025) · low 0 (2007)2025

MAUDE reports naming product code QIH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20192—00
20201114500
20211912500
20222513400
20234515100
20246414102
20259415004
2026781301—

What is it indicated for?

TumorSight Viz is intended to be used in the visualization and analysis of breast magnetic resonance imaging (MRI) studies for patients with biopsy proven early-stage or locally advanced breast cancer. TumorSight Viz supports evaluation of dynamic MR data acquired from breast studies during contrast administration. TumorSight Viz performs processing functions (such as image registration, subtractions, measurements, 3D renderings, and reformats).

TumorSight Viz also includes user-configurable features for visualizing and analyzing findings in breast MRI studies. Patient management decisions should not be made based solely on the results of TumorSight Viz.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K231130: TumorSight Viz.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K231130

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026